How Many People Die From Cervical Cancer Every Day

Picture two girls born on the same day, one in a town in Scotland and one in a village in southern Malawi. At 12, the Scottish girl rolls up her sleeve in a school hall and gets a vaccine that takes about ten seconds. At 25, a letter arrives inviting her for a smear test, and it keeps arriving every few years after that. The girl in Malawi never sees the vaccine, and nobody ever offers her a test.

If both live to 50, their chances of dying from cervical cancer are worlds apart. The disease is caused almost entirely by a virus we can vaccinate against, and it grows so slowly that screening can catch it years before it becomes dangerous. Yet it still kills hundreds of thousands of women every year. Few cancers show the gap between what medicine can do and what the world actually delivers as clearly as this one.

The headline number

Cervical cancer killed around 348,000 women worldwide in the most recent global estimate from the International Agency for Research on Cancer (IARC), published as GLOBOCAN 2022. About 661,000 women were diagnosed in the same year.

That works out to roughly 950 deaths every day, or about one every 90 seconds. Every one of those deaths is added to the total on our live death counter, where cancer of all kinds accounts for about one death in six.

Time period	Cervical cancer deaths (approx.)
Per minute	0.66
Per hour	40
Per day	954
Per week	6,700
Per month	29,000
Per year	348,000

Cervical cancer is the fourth most common cancer in women worldwide and the fourth leading cause of cancer death in women, behind breast, lung and bowel cancer. In large parts of sub-Saharan Africa it is number one.

How it compares with other cancers

Among all cancers, cervical cancer sits around ninth for deaths. That ranking hides something important, because it only affects women and it tends to strike younger than most cancers. The figures below come from the same GLOBOCAN 2022 release, so they are directly comparable.

Cancer	Deaths per year (approx.)	Deaths per day
Lung	1,820,000	4,990
Bowel (colorectal)	904,000	2,480
Liver	758,000	2,080
Breast	666,000	1,820
Stomach	660,000	1,810
Pancreas	467,000	1,280
Prostate	397,000	1,090
Cervix	348,000	954
Ovary	207,000	570

For the women's cancers next to it in that table, see our pieces on breast cancer deaths and ovarian cancer deaths. Our cancer overview page shows the combined live toll of every type, and the wider picture for women is in the leading causes of death in women.

Why it is almost entirely preventable

The World Health Organization estimates that around 95% of cervical cancers are caused by persistent infection with the human papillomavirus (HPV). HPV is extremely common. Most sexually active people pick it up at some point, and in most cases the immune system clears it within a year or two without any symptoms.

The trouble starts when a high-risk type, mainly HPV 16 or 18, hangs around for years. It slowly changes the cells of the cervix, first into abnormal but harmless cells, then into pre-cancer, and finally, often 15 to 20 years after infection, into invasive cancer. That long, slow timeline is exactly why prevention works so well. There are two separate chances to stop it.

Stage	What happens	How it is stopped
Before infection	No HPV present	HPV vaccine, ideally age 9 to 14
Persistent HPV infection	Virus present, cells still normal	HPV screening test spots the virus
Pre-cancer (CIN)	Abnormal cells on the cervix	Simple treatment removes the cells
Early cancer	Cancer confined to the cervix	Surgery or radiotherapy, high cure rate
Advanced cancer	Spread beyond the cervix	Treatment far less likely to cure

A small number of risk factors make persistent infection more likely. Smoking roughly doubles the risk of cervical cancer in women with HPV (our smoking deaths article covers the wider damage). The biggest amplifier is HIV: the WHO says women living with HIV are about six times more likely to develop cervical cancer, which is a large part of why rates are so high in southern and eastern Africa. Our HIV/AIDS page tracks those deaths separately.

Where women die from it

This is a cancer of inequality. The WHO estimates that around nine in ten cervical cancer deaths happen in low and middle-income countries. The absolute numbers are largest in the most populous countries, while the highest rates are in Africa.

Country	Approx. deaths per year	Why
India	80,000	Huge population, limited screening coverage
China	56,000	Large population, screening expanding
Indonesia	over 20,000	Late diagnosis common
Nigeria	8,000	Low screening and vaccine coverage
United States	4,300	Most deaths in unscreened women
United Kingdom	850	Long-running screening and vaccination

Measured as a rate rather than a raw count, the picture flips. The highest death rates in the world are in countries such as Eswatini, Malawi, Zambia, Zimbabwe and Tanzania, where cervical cancer is the most common cancer killer of women. Age-adjusted death rates there are often ten times higher than in Western Europe. Our Africa region page puts those countries in the wider context of the continent's mortality, and our Asia region page does the same for the countries with the largest absolute numbers.

It strikes younger than most cancers

Most cancer deaths happen after 70. Cervical cancer is different. It is most often diagnosed between the ages of 30 and 50, which means it frequently kills women who are raising children, working and caring for older parents. Each death removes far more years of life than a typical cancer death does.

Age group	Typical role of cervical cancer
Under 25	Very rare
25 to 34	Diagnoses begin to rise sharply
35 to 49	Peak years for diagnosis
50 to 69	Deaths peak, especially in unscreened women
70 and over	Still occurs, often in women who stopped screening

Our age-group pages show how cancer fits into the overall picture for people aged 30 to 49 and people aged 50 to 69. In many African countries, cervical cancer is one of the main reasons women in their forties die.

The vaccine is already working

The HPV vaccine is one of the clearest success stories in modern prevention, and the real-world results are now in.

• Sweden: a study of more than 1.6 million women, published in the New England Journal of Medicine in 2020, found that women vaccinated before age 17 had an 88% lower risk of invasive cervical cancer.
• England: research published in The Lancet in 2021 found cervical cancer rates were around 87% lower in women offered the vaccine at age 12 to 13 than in earlier unvaccinated groups.
• Scotland: a 2024 study found no cases at all of cervical cancer among women fully vaccinated at 12 or 13 under the routine programme.

In 2022, the WHO advised that a single dose gives strong protection, which makes the vaccine far cheaper and easier to deliver. The obstacle is coverage. WHO and UNICEF figures show that only around a quarter to a third of girls worldwide have had even one dose, and coverage in many of the countries with the highest death rates is far lower.

Screening: the second safety net

Screening finds HPV or abnormal cells years before cancer develops. Most rich countries now test directly for high-risk HPV rather than looking at cells under a microscope first, because the HPV test is more sensitive and lets women be screened less often.

Country	Who is invited	How often
England	Women and people with a cervix, 25 to 64	Every 3 years (25 to 49), every 5 years (50 to 64)
Scotland and Wales	25 to 64	Every 5 years if HPV negative
United States	21 to 65 (guidance varies)	Every 3 to 5 years depending on test
Australia	25 to 74	Every 5 years, self-collection allowed

England moved to five-year intervals for 25 to 49 year olds who test HPV negative in July 2025, and home self-sampling kits are being offered to people who are overdue. Even so, NHS figures show roughly one in three eligible people in England are not up to date, and younger women are the least likely to attend. In the United States, more than half of cervical cancers are found in women who have never been screened or have not been screened in the past five years.

Survival depends heavily on catching it early. In the United States, the five-year relative survival rate is about 91% when the cancer is confined to the cervix, around 60% when it has spread to nearby tissue, and under 20% once it has reached distant organs.

The plan to eliminate it

In 2020, the WHO launched a global strategy to eliminate cervical cancer as a public health problem, defined as fewer than 4 new cases per 100,000 women per year. It was the first time all 194 member states had committed to eliminating a cancer. The plan rests on three targets for 2030, known as 90-70-90.

Target	Goal by 2030
Vaccination	90% of girls fully vaccinated by age 15
Screening	70% of women screened with a high-quality test by 35, and again by 45
Treatment	90% of women with pre-cancer or cancer receiving treatment

Modelling published alongside the strategy estimated that meeting these targets could avert around 62 million cervical cancer deaths by 2120. Australia is on track to reach elimination around 2035, and NHS England has set a goal of eliminating it by 2040. Every year in January, Cervical Cancer Awareness Month pushes the same message, and World Cancer Day in February carries it into the wider cancer conversation.

Symptoms worth knowing

Early cervical cancer often causes no symptoms at all, which is why screening matters so much. When symptoms do appear, the most common are:

• Bleeding between periods, after sex or after the menopause
• Unusual vaginal discharge
• Pain during sex
• Pain in the lower back, pelvis or lower tummy

These are usually caused by something far less serious, but they are worth getting checked by a GP or doctor, even if a recent screening test was clear. Screening is for people without symptoms; it is not a reason to ignore symptoms when they appear.

What the numbers really say

Cervical cancer is not a mystery disease. Scientists know what causes it, how long it takes to develop and how to stop it at every stage. The 348,000 deaths a year are mostly the result of where women live, not what science can do. A girl vaccinated today in a country with good screening has a lifetime risk close to zero; a girl in a country with neither still faces one of the leading causes of death for women her age.

If you want to see how your own health habits shape your long-term odds, try our risk calculator. For a broader look at how cancer stacks up against every other killer, read our article on how many people die from cancer every day, and compare it with the related story of stomach cancer, another cancer driven by an infection that can be treated.

While you were reading

This article takes about 12 minutes to read. In that time, roughly 8 women around the world died from cervical cancer, most of them in their forties and fifties, and most in countries where a vaccine and a simple test were never offered. You can watch the global total keep climbing on our live death counter.

Data sources: International Agency for Research on Cancer, GLOBOCAN 2022 (Global Cancer Observatory); World Health Organization cervical cancer fact sheet and Global Strategy to Accelerate the Elimination of Cervical Cancer (2020); WHO and UNICEF immunisation coverage estimates; Lei et al., New England Journal of Medicine (2020); Falcaro et al., The Lancet (2021); Palmer et al., Journal of the National Cancer Institute (2024); NHS England cervical screening guidance; American Cancer Society Cancer Facts and Figures; Cancer Research UK. Country figures are rounded estimates and may differ slightly from national registry data.

This article is for general information only and is not medical advice. If you have symptoms or questions about screening or vaccination, speak to your GP or a qualified health professional.